BP214

Lidocaine hydrochloride

British Pharmacopoeia (BP) Reference Standard

• Sinonimo/i: Lidocaine hydrochloride monohydrate, 2-Diethylamino-N-(2,6-dimethylphenyl)acetamide hydrochloride monohydrate, Lignocaine hydrochloride monohydrate, Xylocaine hydrochloride monohydrate
• Formula empirica (notazione di Hill): C₁₄H₂₂N₂O · HCl · H₂O
• Numero CAS: 6108-05-0
• Peso molecolare: 288.81
• Numero CE: 200-803-8
• Numero MDL: MFCD00150329
• Codice UNSPSC: 41116107
• NACRES: NA.24

Proprietà

• Grado: pharmaceutical primary standard
• Famiglia di API: lidocaine
• Stato: solid
• Durata: limited shelf life, expiry date on the label
• Produttore/marchio commerciale: BP
• applicazioni: pharmaceutical; pharmaceutical small molecule
• Formato: neat
• Temperatura di conservazione: 2-8°C
• Stringa SMILE: Cl[H].[H]O[H].CCN(CC)CC(=O)Nc1c(C)cccc1C
• InChI: 1S/C14H22N2O.ClH.H2O/c1-5-16(6-2)10-13(17)15-14-11(3)8-7-9-12(14)4;;/h7-9H,5-6,10H2,1-4H3,(H,15,17);1H;1H2; YECIFGHRMFEPJK-UHFFFAOYSA-N
• Informazioni sul gene: human ... SCN10A(6336) , SCN11A(11280) , SCN1A(6323) , SCN2A(6326) , SCN3A(6328) , SCN4A(6329) , SCN5A(6331) , SCN7A(6332) , SCN8A(6334) , SCN9A(6335)

Descrizione

Descrizione generale

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Applicazioni

Lidocaine hydrochloride BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia.

Also used in monographs such as:

Bupivacaine and Adrenaline Injection / Bupivacaine and Epinephrine Injection

Lidocaine and Adrenaline Injection / Lidocaine and Epinephrine Injection

Mepivacaine Injection

Lidocaine Intraocular Injection

Azioni biochim/fisiol

Na⁺ channel blocker; class IB antiarrhythmic that is rapidly absorbed after parenteral administration

Na⁺ channel blocker; class IB antiarrhythmic.

Confezionamento

Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia

Altre note

Sales restrictions may apply.

Informazioni sulla sicurezza

• Pittogrammi: GHS06
• Avvertenze: Danger
• Indicazioni di pericolo: H301
• Consigli di prudenza: P301 + P330 + P331 + P310
• Classi di pericolo: Acute Tox. 3 Oral
• Codice della classe di stoccaggio: 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
• Classe di pericolosità dell'acqua (WGK): WGK 3
• Punto d’infiammabilità (°F): Not applicable
• Punto d’infiammabilità (°C): Not applicable